DS Healthcare Discloses New Board Members

POMPANO BEACH, FL, April 4, 2016 (Newswire.com) - ​DS Healthcare (DSKX) shareholders have proposed the following Board Members to be elected as soon as possible. One of the new Board Members, Yasuhiro Fujiwara intends to increase his investment in DS Healthcare by acquiring a significant percentage of common stock on the open market.

The new Board of Directors will be composed of members who are completely independent to enhance corporate governance. The proposed Board Members are as follows:

Yasuhiro Fujiwara

Yasuhiro Fujiwara served as the Head of Equities for Asia, Ex-Japan at Nomura Holdings, Inc. from March 2013 to January 2015. Yasuhiro Fujiwara served as Co-Head of Asia-pacific Global Markets at BofA Merrill Lynch.

Elina Yuabov, ESQ.

Elina is the central point of contact at TD Securities for G20 regulatory training. Extensive focus on Dodd-Frank Title VII (EBCS, STRD, Port Rec, Mandatory Clearing, Margin for Non-Centrally Cleared, Swap Push Out, FATCA) EMIR, Canadian, Singapore and Australian legal regulatory analysis and implementation. SEC security based swaps regulatory analysis and execution of policies and procedures for CFTC, OSC and ASIC review and audits.

Myron Lewis

Myron Lewis has over 40 years of experience as Manager/Vice President/President/Founder/CEO of various companies in Technology, Marketing Communications/Public Relations, Applied Research, Defense (U.S. Government) and Manufacturing such as MU-Vision Inc. and KeyGen Corporation.

About DS Healthcare Group

DS Healthcare Group Inc. develops novel biotechnology for topical therapies. It markets through online channels, specialty retailers, distributors, pharmacies, and salons. Its research has led to a highly innovative portfolio of personal care products and additional innovations in pharmaceutical projects. For more information on DS Healthcare Group's flagship brand, visit www.dslaboratories.com

Forward-looking statements

Except for statements of historical fact, the matters discussed in this press release are forward-looking and made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies, and are generally preceded by words such as "future," "plan" or "planned," "expects," or "projected." These forward-looking statements reflect numerous assumptions and involve a variety of risks and uncertainties, many of which are beyond the company's control that may cause actual results to differ materially from stated expectations. These risk factors include, among others, limited operating history, difficulty in developing and marketing products, intense competition, and additional risks factors as discussed in reports filed by the company with the Securities and Exchange Commission, which are available at http://www.sec.gov

Contact:

Investor Relations
DS Healthcare Group
(888) 404-7770 ext. 3
Investors@DSHealthgroup.com